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A B S T R A C T
The potential health risks associated with (re-)emerging positive-strand RNA (+RNA) viruses emphasizes
the need for understanding host-pathogen interactions for these viruses. The innate immune system
forms the first line of defense against pathogenic organisms like these and is responsible for detecting
pathogen-associated molecular patterns (PAMPs). Viral RNA is a potent inducer of antiviral innate
immune signaling, provoking an antiviral state by directing expression of interferons (IFNs) and pro-
inflammatory cytokines. However, +RNA viruses developed various methods to avoid detection and
downstream signaling, including isolation of viral RNA replication in membranous viral replication
organelles (ROs). These structures therefore play a central role in infection, and consequently, loss of RO
integrity might simultaneously result in impaired viral replication and enhanced antiviral signaling. This
review summarizes the first indications that the innate immune system indeed has tools to disrupt viral
ROs and other non- or aberrant-self membrane structures, and may do this by marking these membranes
with proteins such as microtubule-associated protein 1A/1B-light chain 3 (LC3) and ubiquitin, resulting
in the recruitment of IFN-inducible GTPases. Further studies should evaluate whether this process forms
a general effector mechanism in +RNA virus infection, thereby creating the opportunity for development
of novel antiviral therapies.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The innate immune system forms the first line of defense
against pathogens and its initial function is to recognize pathogen-
associated molecular patterns (PAMPs) [1], which ultimately leads
to induction of the antiviral state that effectively hampers spread
of the infection. The adaptive immune system then kicks in to (in
most cases) fully clear the virus and build up memory. Viral RNA is
a very potent inducer of innate antiviral signaling [2,3]. Therefore,
detection of viral RNA and the subsequent induction of antiviral
effector mechanisms play an important part in the onset of an
antiviral state in the context of RNA virus infections. The study of
PAMP recognition and signaling by cytosolic and membrane bound
sensors has intensified tremendously in the last decade. Several
comprehensive reviews on this subject have been published lately
[4,5]. Additionally, investigation of the involvement of intracellular
organelle membranes of mitochondria, ER, and peroxisomes and
their mutual interactions indicated that these are important
signaling platforms in innate immunity [6,7]. Together, this has
resulted in a better understanding of the details of innate immune
responses that target RNA viruses.
In this review, we will focus on the interaction of the innate
immune system with viruses that have a positive-strand RNAder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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all +RNA viruses interfere to delay antiviral innate immune
signaling in several ways [1,8,9]. A key feature of immune evasion
by +RNA viruses, and simultaneously the hallmark of +RNA virus
infection, is rearrangement of host membranes into viral replica-
tion organelles (ROs). As these structures are thought to shield viral
RNA from the host innate immune system and additionally seem to
play a fundamental role in viral RNA replication, ROs in this sense
seem to have a central and dual function in viral replication [10–
14]. Therefore, disrupting integrity of ROs might simultaneously
result in impaired viral replication and enhanced antiviral immune
signaling, which would be a beneficial effect from an antiviral
immunity point-of-view. However, whether host cells possess
effector mechanisms to disrupt +RNA virus ROs has hardly been
investigated yet, and only quite recently some studies have shed
more light on this, which will be the focus of this review together
with the body of literature that surrounds it.
2. Positive-strand RNA viruses: societal impact, taxonomy, and
virus-induced replication organelles
Positive-strand RNA viruses have caused multiple outbreaks
during the past decade: severe acute respiratory coronavirus
(SARS-CoV) infected more than 8000 individuals in 2003 of which
almost 800 died [15]. Its close relative Middle East respiratory
syndrome coronavirus (MERS-CoV) emerged in Saudi Arabia in
2012. While SARS-CoV infections have not been reported in
humans after 2004, MERS-CoV currently still regularly occurs in
dromedary camels as well as in humans, and the virus displays a
lethality rate of around 35% in the latter [16]. Zika virus, which
received a lot of societal attention lately, is an example of a re-
emerged +RNA virus with significant impact [17]. These outbreaks,
and the lack of tailored antiviral strategies against them, clearly
illustrate the potential health risks associated with (re-)emerging
+RNA viruses, and emphasize the need for a precise understanding
of host-pathogen interactions to facilitate development of novel
antiviral therapies or vaccination methods. Over the last decades,
many +RNA viruses have been extensively studied for their
intriguing biology, including coronaviruses as those mentioned
above, picornaviruses such as coxsackievirus and poliovirus, and
flaviviruses such as West Nile virus (WNV), Hepatitis C virus (HCV),
dengue virus (DENV), Zika virus, and Japanese encephalitis virus
(JEV), as well as the family of togaviridae, including rubella virus
and chikungunya virus.
One of the intriguing features that is shared by all +RNA viruses
is the rearrangement of host membranes into viral ROs, whereby
particular cellular organelles (depending on the virus) are used asFig. 1. Viral replication organelles. (A) Schematic representation of viral replication or
categorized as the invaginated vesicle/spherule (Inv) type (left), and the double membra
with alphaviruses, such as Semliki Forest virus (SFV), nodavirideae such as flock house v
West Nile virus (WNV). Alternatively, double membrane vesicle (DMV) type ROs are for
severe acute respiratory coronavirus (SARS-CoV) and equine arteritis virus (EAV), and t
infection, modified from [21] (C) 3D reconstruction of DMV ROs upon HCV infection mmembrane donors. Concerning their role in viral RNA replication, it
is thought that the structures form a scaffold that improves
efficiency of enzymatic reactions and provides a spatiotemporal
regulation of the different stages in the virus life cycle. Besides this,
it is thought that ROs have an important role in shielding viral RNA
products from the RNA sensors of the innate immune system. ROs
are therefore believed to have a dual role in +RNA virus infection
and innate immune evasion, which will be elaborated on further in
this review. Several comprehensive reviews have recently de-
scribed the current knowledge of these structures [12,18–20],
therefore we will only briefly summarize this below. Most studies
until now focused on the architecture of structures induced by
different viruses, and based on electron microscopy and electron
tomography, ROs were categorized into two different classes: the
invaginated vesicle/spherule (Inv) type, and the double membrane
vesicle (DMV) type (Fig. 1).
Inv ROs are predominantly observed during infection with
alphaviruses, such as Semliki Forest virus and Sindbis virus,
nodavirideae such as Flock House virus, bromoviridae such as
bromovirus, and flaviviridae such as rubella virus, DENV, and WNV
[19,21]. Although the location and dynamics of the formation of Inv
ROs varies per virus, the result is a single membrane invagination
of which the content is connected to the cytosol. In addition,
replicase proteins and newly synthesized viral RNA were observed
in these spherules, strongly suggesting that Inv ROs are sites of
viral RNA replication [22–24]. Furthermore, ribosomes are found in
close proximity of some Inv ROs [25], suggesting that viral RNA
replication and translation are spatially separated. A similar
organization of Inv ROs was found for Flock House virus, rubella
virus, DENV, and WNV. Moreover, a recent study visualized virus
budding in close association with Inv ROs, suggesting a direct role
for these structures in coordinating virus assembly [26].
Alternatively, DMV ROs are known to be formed by enter-
oviruses such as coxsackievirus B3 and poliovirus, coronaviruses
such as SARS-CoV and MERS-CoV, arteriviruses such as equine
arteritis virus (EAV), and the flavivirus HCV [19,27]. Besides DMVs,
for most of these viruses other kinds of structures are found during
infection, mostly in close proximity to the DMVs themselves, such
as single membrane vesicles, multi-membrane vesicles, vesicle
packets, tubular structures or zippered ER membrane. As for Inv
ROs, replicases and viral RNA of poliovirus, EAV, and coxsackievirus
B3 were demonstrated to localize to DMVs, suggesting that these
structures might also support viral RNA replication. Likewise, for
HCV replicase proteins and viral RNA were predominantly found in
DMVs, and the number of DMVs positively correlated to the
amount of viral RNA produced, suggesting that DMVs indeed serve
as sites of RNA replication. However, for coronaviruses, the numberganelles (ROs), modified from [18]. Membranous structures that form ROs can be
ne vesicle (DMV) type (right). Inv ROs are predominantly observed during infection
irus (FHV), and flaviviridae such as rubella virus (RUBV), dengue virus (DENV), and
med by enteroviruses coxsackievirus B3 (CVB3) and poliovirus (PV), coronaviruses
he flavivirus hepatitis C virus (HCV). (B) 3D reconstruction of Inv ROs upon DENV
odified from [27].
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[28,29]. Also, whereas SARS-CoV dsRNA (a replication intermedi-
ate) was found inside DMVs, replicase proteins were more
abundant in surrounding convoluted membranes, raising ques-
tions regarding the spatial organization of SARS-CoV RNA
replication. The lack of clear connections between the inside of
corona- and arterivirus-induced DMVs and the cytosol (where the
RNA products have to go for translation and particle formation)
further complicates our current understanding of coronavirus
DMV functionality [30,31]. Together, these data continue to cause
debate on the exact function of DMVs and other features of DMV
ROs. The notion that expression of combinations of non-structural
viral proteins (nsps) for some of these viruses mimics the
formation of membrane alterations as observed during infection
confirms the viral induction of these structures and opens
possibilities for detailed study of this particular feature of the
infection [32–34].
3. Innate immune recognition and responses targeted towards
viral RNA replication, transcription, and translation
3.1. Innate immune detection of viral RNA establishes an antiviral state
Rapid production of interferons (IFNs) and pro-inflammatory
cytokines is an important consequence of virus detection, as it
contributes to an antiviral state in both the infected host cell and
the (un)infected surrounding cells. In addition, IFNs play an
essential role in coordinating the antiviral adaptive immune
response, which has been reviewed elsewhere [35]. Three types of
IFNs have been described. Type I IFNs consist of 13 subtypes of IFN-
a and a single subtype of IFN-b, IFN-d, IFN-e, IFN-k, IFN-t and IFN-
v. Type II IFN only contains one subtype of IFN-g, and type III IFNs
comprise of IFN-l1 through l4. Whereas it is known that most
cell types produce type I IFNs in response to viral infection, type II
IFNs are only produced after antigenic stimulation of an expanding
group of certain immune cells, including T-cells, natural killer cells,
dendritic cells, and macrophages [36,37]. In contrast, little is
known about type III IFN production in vitro and in vivo, although it
is believed that most cell types that produce type I IFNs are capable
of producing type III IFNs as well [38]. Most cells are able to
respond to IFN-I and II, whereas IFN-III receptors are mainly
found on epithelial cells [39]. The protective role of IFNs during
viral infection is for example illustrated by inhibitory effects of IFN-
a, IFN-b, and IFN-g on SARS-CoV replication in vitro and in vivo
[40–43]. Importantly, correct timing and amount of IFN and
subsequent pro-inflammatory cytokine expression is essential for
an effective antiviral immune response, as delayed and/or elevated
induction may stimulate immunopathological outcomes [35].
Below we will focus on the interactions of the innate immune
system with the RNA replication stages of +RNA virus infection,
including exposure of viral RNA to the cytosol after the unpacking
of virus particles, and formation of ROs by the virus. We will also
discuss examples of viral evasion surrounding these processes.
IFN-I and –III production is triggered after host cells detect viral
RNA, primarily using cytosolic RIG-I like Receptors (RLRs) and
membrane-bound Toll-like receptors (TLRs). RLRs retinoic acid-
inducible gene I (RIG-I) and melanoma differentiation associated
factor 5 (MDA5) have been studied extensively (reviewed in
[44,45]). Besides their role in RNA metabolism, RIG-I and MDA5
recognize viral RNA by binding phosphorylated 50 termini (50ppp-
RNA) in combination with dsRNA or ssRNA motifs. Detection of
viral RNA activates RLRs and triggers downstream signaling
through the mitochondrial antiviral signaling (MAVS) adaptor,
which is localized on the outer mitochondrial membrane [46–49].
The importance of MAVS is underscored by the observation that
silencing of this protein by RNA interference abolishes expressionof type I IFNs [46]. Subsequently, MAVS recruits various adaptor
molecules such as Stimulator of interferon genes (STING) and TNF
receptor-associated factors, resulting in the formation of large
signaling complexes [50]. Ultimately, this leads to activation of
kinase complexes IKKe/TBK1 and IKKa/IKKb/IKKg, resulting in
activation of interferon regulating factor 3 (IRF3), 7 (IRF7) and NF-k
B. These transcription factors then translocate to the nucleus and
initiate the expression of IFNs and pro-inflammatory cytokines.
Besides the role of RLRs, other RNA sensing molecules have
been shown to participate in antiviral responses. For example, of
the 10 types of TLRs described in humans, endosomal TLRs 3, 7, and
8 are known to have a role in viral RNA detection. A detailed
overview on the role of TLRs in antiviral signaling can be found
elsewhere [51]. Briefly, TLRs interact with various adaptor
molecules after stimulation, and the combination of recruited
adaptors influences downstream signaling events. TLR3 eventually
recruits common adaptor molecule TIR-domain-containing adapt-
er-inducing interferon-b (TRIF), whereas TLRs 7 and 8 engage
myeloid differentiation primary response gene 88 (MyD88). As in
RLR signaling, this leads to activation of kinase complexes IKKe/
TBK1 and IKKa/IKKb/IKKg. Furthermore, Protein kinase R (PKR)
and 20,50-oligoadenylate synthetase (OAS) have been demonstrated
to induce antiviral activities upon binding of dsRNA, as is described
in detail elsewhere [45]. Well-established examples of antiviral
activity provoked by PKR include inhibition of translation and
inflammasome activation, and OAS activates RNase L to initiate
degradation of host and viral RNA. In addition, PKR and OAS have
been suggested to amplify RLR-mediated antiviral immune
signaling [45].
The production and release of IFNs and pro-inflammatory
cytokines contributes to an antiviral state in both infected host
cells and in (un)infected surrounding cells. Despite the presence of
multiple IFN and receptor types [52], the Janus kinase-signal
transducer and activator of transcription (JAK/STAT) pathway is
utilized by all IFNs to establish expression of interferon-stimulated
genes (ISGs). The observation that a deficiency in separate IFN
receptors did not affect disease progression during murine SARS-
CoV infection, in contrast to a deficiency in common signaling
molecule STAT1, illustrates this high degree of redundancy [53]. At
the moment, hundreds of ISGs have been identified. However, an
exact function has only been clarified for a relatively low number of
the corresponding proteins, a description of which can be found
elsewhere [54–56]. Nonetheless, these studies suggest that ISGs
exhibit overlapping inhibitory activity towards most components
of virus replication, including virus entry, uncoating, translation of
viral proteins, RNA replication, and egress [54]. In summary, host
cells detect viral RNA by several detection mechanisms to establish
an antiviral state via the induction of IFNs and pro-inflammatory
cytokines, leading to expression of ISGs.
3.2. Antiviral innate immune signaling is spatially organized
As mentioned earlier, MAVS localized on mitochondria is a key
player in antiviral signaling. Therefore, studies demonstrating that
the MAVS adaptor molecule STING is located on the ER implied that
earlier identified contacts between mitochondrial membranes and
ER membranes (mitochondrion-associated membranes: MAMs)
were possibly involved in antiviral signaling [57]. In support of this
theory, expression of a MAM-enriched marker protein followed by
cell fractionation revealed that MAVS localizes to MAMs, which
was supported by immunofluorescence assays of MAVS and MAM-
enriched proteins [58]. Additionally, immunoprecipitation analysis
of the MAM fraction of Sendai virus-infected hepatocytes
confirmed that MAM-localized MAVS interacts with RIG-I and
signaling cofactor TRAF3 [58], indicating that MAMs are involved
in the RLR-mediated antiviral immune signaling pathway.
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govern expression of type I and III IFNs. Interestingly, MAVS is also
expressed on peroxisomal membranes, and interacts with
stimulated RLRs during viral infection [59]. However, in contrast
to its mitochondrial counterpart, peroxisomal MAVS was found to
induce expression of ISGs by an IFN-independent mechanism, and
this relatively rapid process seems to provide short-term protec-
tion until the IFN-dependent expression of ISGs mediated by other
viral RNA-sensing mechanisms is established [59]. Interestingly,
recent studies found that direct contacts between peroxisomes and
ER membranes were involved in maintaining peroxisomal function
[60–62], raising the question whether these contact sites might
also regulate antiviral immunity-related processes. In summary,
peroxisomal and mitochondrial membranes and their contact-
sites with the ER are important regions for converting viral RNA
detection by RLRs to downstream events required for establishing
an antiviral state.
Besides MAMs, increasing evidence suggest a role for stress
granules (SGs) in antiviral immune signaling. SGs are non-
membranous compartments in the cell that contain aggregates of
ribonucleoprotein (RNP) and mRNA, and are formed as a
physiological response to various stress stimuli that cause temporal
stalling of mRNA translation, suggestively preventing accumulation
[63]. Consistent with the function of this structure, inhibition of
translation through the inactivation of eukaryotic translation
initiation factor (eIF)2a by phosphorylation is an important cue
for SG formation [63]. Considering that various RNA virus infections
result in shutdown of host translation by inactivation of eIF2a by for
example PKR, it is now known that formation of SGs occurs to
different extends during infection with various RNA viruses,
including HCV, DENV, and SFV [63,64]. Interestingly, multiple lines
of evidence have demonstrated that SGs in encephalomyocarditis
virus- or influenza virus-infected cells contain multiple RNA sensing
molecules that were found to contribute to IFN production in vitro,
including RIG-I, MDA5, PKR, OAS, RNaseL, and dsRNA [65,66].
However, it should be noted that the contribution of SGs to
antiviral signaling differs per virus, as SG-localized MDA5, an RLR
that greatly contributes to IFN induction upon encephalomyocar-
ditis virus infection, was not found to support IFN expression upon
infection with this virus [67]. Nonetheless, these findings suggest
an important role for SGs as detection platforms for viral RNA.
Taken together, increasing evidence suggests that the antiviral
innate immune signaling cascade is spatially organized, and since
different structures in the cell seem to be specialized in a particular
aspect of this process, it can be hypothesized that interaction
between these structures plays a fundamental role in orchestrating
the antiviral innate immune response.
4. Positive-strand RNA viruses interfere with antiviral innate
immune signaling
4.1. Shielding viral RNA species away from innate immune sensors
Positive-strand RNA viruses developed multiple mechanisms to
impair RNA recognition and antiviral signaling (also reviewed in
[8]). As mentioned above, the presence of viral RNA in ROs suggests
a role for ROs in shielding viral RNA from the innate immune
detection machinery. While there is no unequivocal evidence
supporting this theory, the finding that isolated viral RNA-
containing membrane alterations only become sensitive to
nuclease treatment after membrane disruption by nonionic
detergents supports this hypothesis [68–71]. In addition, a positive
correlation between cytosolic exposure of viral RNA and IFN
induction was recently found by an in vitro comparison of JEV and
DENV infections [72]. Another important strategy by which RNA
viruses avoid recognition is their modification of viral RNAmolecules to mimic eukaryotic mRNA. For example, the formation
of a 50 cap is catalyzed by viral phosphatases and methyltransfer-
ases in some viral families such as the coronaviruses. From work on
mouse hepatitis virus (MHV) it became clear that coronaviruses
need to take care of N-linked as well as 20O-linked methylation on
the CAP structure, in order to avoid recognition by innate immune
sensors [73]. Mimicry of eukaryotic RNA in this way was shown to
be an important immune evasion strategy by +RNA viruses such as
SARS-CoV and JEV [74,75]. A recent report indicated that
coronaviruses also evade dsRNA mediated recognition by PKR
and OAS by using their endonuclease (EndoU), which cleaves free
viral (and cellular) RNA that is somehow exposed to the cytosol, in
order to prevent antiviral signaling [76].
4.2. Active interference with innate immune signaling by viral proteins
In addition to avoidance of recognition, +RNA viruses actively
interfere with antiviral signaling components to impair expression
of IFNs and pro- inflammatory cytokines. Very often, the viral
proteases that are expressed by +RNA viruses, and which mostly
have a primary function in cleavage of viral replicase polyproteins,
seem to have a prominent role in this. For example, HCV NS3/4A
and DENV NS4A cleave MAVS [47,77–82], and the DENV protease
complex and HCV NS4B inhibit adaptor molecule STING by
cleaving it [83–87]. Additionally, human CoV NL63 and SARS-
CoV nsp3 possess a papain-like protease (PLP) domain that
prevents dimerization of STING and its complex formation with
MAVS and IKKe, and almost all nidovirus-encoded PLPs have been
shown to display deubiquitinating activity [88]. Several have been
suggested to facilitate deubiquitination of innate immune factors
such as STING, RIG-I, TBK1 and IRF3 in order to halt innate immune
signaling [8]. Moreover, in collaboration with others, our lab
demonstrated that EAV and MERS-CoV virus mutants that lack the
DUB activity of their PLPs while retaining polyprotein cleavage
functions suppress IFN production less efficiently during infection
([89,90] and our unpublished data). Furthermore, viral proteins
such as DENV NS2B/3 and the SARS-CoV membrane glycoprotein
interfere with complex formation of IKKe/TBK1 and IKKa/IKKb/
IKKg or downstream transcription factors, thereby effectively
inhibiting both RLR and TLR signaling [91,92]. Interestingly,
accessory proteins encoded by open reading frames of CoVs have
been shown to be involved in inhibition of IRF3, IRF7, and NF-kB by
undefined mechanisms [93,94]. In addition, several methods are
employed by +RNA viruses to interfere with JAK/STAT signaling. For
instance, JEV NS5 and WNV NS4 B inhibit phosphorylation and
activation of JAK1, and suppressors of JAK1 are induced by viruses
such as WNV, JEV, and chikungunya virus [95–99]. However, STAT1
and STAT2 are most heavily targeted. JEV NS5, WNV and DENV
NS4B, and JEV NS4A have been shown to inhibit STAT activation. In
addition, DENV NS5 promotes proteasomal degradation of STAT2.
Interestingly, SARS-CoV inhibits STAT1 signaling in three different
ways. Firstly, SARS-CoV nsp1 binds STAT1 to inhibit its phosphor-
ylation [100]. Secondly, the accessory protein encoded by SARS-
CoV open reading frame 6 prevents nuclear transport of STAT1
[93,101]. Thirdly, SARS-CoV PLP induces expression of E3 ubiquitin
ligase E2–25k, which promotes proteasomal degradation of
extracellular signal-regulated kinase 1, a protein responsible for
activation of STAT1 [102]. To our knowledge, no studies have been
published (yet) about specific interference of +RNA viruses with
IFN-II production.
4.3. Dysregulation in the spatial organization of the antiviral innate
immune system
Interference of +RNA viruses with antiviral signaling also has
consequences for the spatial organization of the antiviral innate
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antiviral role, interfering with SG formation might constitute an
opportunity for viruses to hamper the innate immune response.
Indeed, various proteins of poliovirus, coxsackievirus, encephalo-
myocarditis virus, DENV, WNV, MERS-CoV, chikungunya virus, and
JEV have been shown to prevent the formation of SGs and thereby
suppress IFN production [63,66,103–109]. Thus, dysregulation of
SGs seems to be a common strategy for +RNA viruses in order to
dampen the innate antiviral immune response. In addition, the
finding that MAMs are involved in the RLR-mediated antiviral
immune signaling pathway shedded new light on the immuno-
suppressive role of viral proteases. By performing colocalization
analysis with a MAM-enriched marker protein and cell fraction-
ation experiments in both uninfected and HCV-infected cells, it
was found that NS3/4A also localizes to MAMs [58]. Intriguingly,
despite the clear function for peroxisomal MAVS in antiviral
signaling, cleaved MAVS was found solely in MAM-enriched cell
fractions. In addition, recent findings suggest that MAMs are also
physically disrupted during DENV infection [110]. Thus, these data
indicate that MAMs are critical locations for antiviral signaling and
have an important role in expression of type I and III IFNs.
Moreover, increasing evidence suggests that at least some +RNA
viruses in fact occupy or hijack MAM-membranes during infection,
as MAMs of HCV-infected cells were found to contain proteins
involved in virus assembly and fully assembled virions [111]. It
remains to be investigated whether MAMs also serve as platforms
for viral assembly of other +RNA viruses. In addition, MAM
disruption as a consequence of DENV infection was followed by the
formation of convoluted membranes at the same location, which
supported DENV replication [110]. Moreover, promoting the
formation of convoluted membranes further repressed the IFN
response, underscoring the importance of MAM disruption in both
the replication and immune evasion of +RNA viruses [110]. Taken
together, these studies underscore the importance of MAMs as key
antiviral signaling platforms, and disruption of MAMs constitutes
an effective immune evasion strategy for +RNA viruses. In
conclusion, +RNA viruses developed divergent methods to delay
antiviral innate immune signaling at multiple levels. In addition,
interference of +RNA viruses with antiviral signaling leads to
spatial disorganization of the antiviral innate immune system, and
future studies will hopefully elucidate the consequences of this
phenomenon in the context of other cellular compartments and
viruses.
5. Specific responses towards viral replication organelles
Assuming that ROs impair antiviral signaling by shielding viral
RNA from the host, it is tempting to hypothesize the existence of
host cell mechanisms aimed to disrupt ROs, thereby exposing viral
RNA and promoting antiviral signaling. The fact that +RNA viruses
display such elaborate activities to inhibit viral RNA recognition
and subsequent signaling, as detailed in the former paragraphs,
supports the view that disruption of RO integrity is a situation
these viruses anticipate dealing with. However, evidence suggest-
ing targeting of ROs by the innate immune system is still scarce,
although it was reported that HCV ROs are attacked by the ISG
Viperin [94]. Additionally, 25-hydroxycholesterol, a product
produced by the ISG cholesterol 25-hydroxylase also modifies
HCV replication organelles [112,113]. Recently, our lab published a
study suggesting that IFN-b signaling also negatively influences
arterivirus ROs, since significantly less were formed and remaining
structures showed drastically different morphology after IFN-b
treatment. The results suggested that the treatment interrupted
biogenesis of these membrane structures rather than breaking
down structures that were already made [114]. Interestingly,
neither Viperin nor 25-hydroxycholesterol was involved in theobserved effects, and the mechanistic details therefore have to be
further investigated.
5.1. The innate immune system disrupts pathogen-containing
membrane rearrangements to expose PAMPs
Other recent data suggest that there may indeed be specific
mechanisms by which the innate immune system tags and
disrupts so-called non- or aberrant-self membrane structures in
the cell [115], which could include viral ROs. Most data originate
from studies focusing on bacteria, fungi, or parasites that reside in
rearranged membranes, known as pathogen-containing vacuoles
(PVs), which prevent detection of cytosolic innate immune sensors
in a similar way as viral ROs are thought to do. Multiple studies
found that enzymes capable of disrupting PVs are GTPases, such as
effector immunity-related p47 GTPases (IRGs) and guanylate-
binding proteins (GBPs), which are part of a family which we will
refer to as IFN-inducible GTPases [116]. Expression of IRGs and
GBPs is induced upon IFN-g stimulation, and leads to their
accumulation on PVs. Subsequently, activation of these GTPases
due to the exchange of GDP for GTP results in membrane disruption
as a consequence of their dynamin-like activity [117]. To prevent
aspecific disruption, host cell membranes contain a set of proteins
that inhibit GTPase activity, known as ‘’guard proteins’’ [118]. Well-
studied pathogens in the context of this process are the protozoan
parasite Toxoplasma gondii (T. gondii), the bacterium Chlamydia
trachomatis and the microsporidian Encephalitozoon cuniculi [119–
125]. Although it remains unclear for most of these pathogens how
IFN-inducible GTPases are recruited towards PVs, recent studies on
T. gondii infection demonstrated that host cells label these
membrane structures, for example with various forms of
microtubule-associated protein 1A/1B-light chain 3 (LC3) to
initiate this process [122–125] (Fig. 2). LC3 is a well-known factor
in the autophagy pathway, and several forms of LC3 exist in the
human proteome, which seem to have overlapping as well as
distinct functions. The human genome encodes homologs LC3A,
LC3B, and LC3C and LC3-like homologs GABARAP, GABARAPL1,
GABARAPL2, and GABARAPL3. We will refer to all of these as LC3
unless stated otherwise. LC3 was initially discovered as an
essential protein for autophagosome formation, which requires
a covalent interaction between cytosolic LC3 (LC3-I) and the
phospholipid phosphatidylethanolamine (PE), after which LC3 is
referred to as LC3-II or lipidated LC3 [126]. However, recent studies
have now revealed that labeling of (foreign) membrane compart-
ments by LC3 conjugation can also have various autophagy-
unrelated consequences, as has been reviewed elsewhere
[127,128]. Interestingly, multiple studies demonstrated that label-
ing of LC3 on PVs recruits IFN-inducible GTPases upon IFN-g
expression during T. gondii infection, resulting in exposure of T.
gondii to the host cell cytosol, thereby triggering anti-bacterial
immune responses [122,123,125]. Considering the function of LC3
in autophagosome formation, Jayoung Choi and co-workers [124]
termed this process Targeting by AutophaGy proteins (TAG). In
addition, a similar role was recently found for ubiquitin, the
versatile regulator of numerous important cellular processes, and
also a well-known autophagy-related protein [129]. A study on T.
gondii and Chlamydia trachomatis infection demonstrated that PVs
are also recognized and labeled by the ubiquitination pathway
upon IFN-g expression, resulting in recruitment and activation of
IFN-inducible GTPases [130]. Importantly, it was shown that
virulent strains of T. gondii and Chlamydia trachomatis interfere
with the deposition of IFN-inducible GTPases on PVs, underscoring
the importance of this mechanism in clearance of associated
infections [119,131,132]. Collectively, these studies demonstrate
the existence of various innate immune responses that result in
tagging and subsequent disruption of non- or aberrant-self
Fig. 2. LC3 recruits IFN-g inducible GTPases to disrupt the parasitophorus vacuole of Toxoplasma gondii. Upon invasion of the host cell, Toxoplasma gondii (T. gondii) resides in a
host-derived membranous structure, termed the parasitophorus vacuole membrane (PVM), to evade immune detection. Recent studies demonstrate that LC3 is conjugated to
the PVM by the LC3 conjugation system, leading to recruitment of IFN-g inducible GTPases to the PVM upon IFN-g stimulation. As a consequence, activation of IFN-g inducible
GTPases leads to membrane disruption of the PVM, and exposure of T. gondii to the innate immune system.
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promoting immune signaling. Importantly, the findings suggest
that IFN-mediated membrane disruption might be a common
principle in clearance of pathogens that use rearranged mem-
branes to support replication and avoid innate immune detection.
5.2. Indications for disruption of +RNA virus ROs by the innate immune
system
Like PVs, ROs induced by +RNA viruses are membranous
compartments that constitute an environment for efficient
replication, simultaneously avoiding immune detection by the
host. Therefore, similar mechanisms might be aimed towards viral
ROs. The observation that ROs induced by various +RNA viruses
consist of a double membrane initially suggested a role for the
autophagy machinery in the formation of these structures.
However, only nonlipidated LC3, and not an intact autophagy
pathway, was found to be essential for viral RO formation and viral
replication upon infection with EAV and MHV [133,134], thereby
contradicting this hypothesis. Interestingly, lipidated LC3 wasFig. 3. A possible role for IFN-inducible GTPases in the targeting of viral replication organ
to decelerate innate immune detection. Viral replication organelles (ROs) are believed to h
efficient RNA replication while shielding viral RNA from the host. Based on current kno
disrupt ROs, thereby exposing viral RNA and promoting antiviral signaling. IFNR: interfound to support IFN-g mediated protection against murine
norovirus (MNV) infection by autophagy-unrelated means [135].
Furthermore, the induction of viral membranous structures by
expression of MNV nsps led to a high colocalization between
ATG16L1, a protein involved in LC3 conjugation, and the MNV
polymerase. Since ATG16L1 determines the site for LC3 conjuga-
tion [136], and the MNV polymerase is associated with ROs, this
further supports the possibility that LC3 conjugation occurs on
ROs. Other supporting in vitro experiments show that conditional
KO of ATG4B inhibits replication of MNV and T. gondii more
effectively compared to wildtype cells [123,135]. In contrast to the
multiple autophagins involved in pre-processing of LC3 for
conjugation, ATG4B is the only human homolog of yeast ATG4
that efficiently deconjugates LC3 from membranes [137], and
therefore plays a major role in negatively regulating the fraction of
conjugated LC3. Several groups have reported enhanced conjuga-
tion of LC3 to membranes during knockdown of ATG4B in various
cell types [138–141], including those used by aforementioned
studies [123,135]. Thus, it is likely that increased lipidated LC3 was
present on ROs and PVMs during experiments in ATG4B-deficientelles. Upon infection, +RNA viruses hamper IFN and ISG induction at multiple levels
ave a dual role in +RNA virus infection and innate immune evasion, as they facilitate
wledge, we hypothesize the existence of host cell IFN-inducible GTPases aimed to
feron receptor.
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Interestingly, findings in other studies are contradictory in the
sense that only LC3-I was observed on ROs of MNV, EAV, and MHV-
infected cells [133–135]. On this note, it is worth mentioning that
LC3-I does not support IFN-g mediated inhibition of viral
replication, as IFN-g mediated inhibition of MNV-infected cells
does not occur in the case of ATG7 deficiency, one of the proteins
responsible for LC3 conjugation [135]. In conclusion, although
there is no unequivocal evidence regarding the presence of
conjugated LC3 on +RNA virus induced ROs, the studies described
above provoke the hypothesis that membrane disruption of viral
ROs mediated by IFN-g inducible GTPases may be part of the innate
immune response against +RNA viruses (Figure 3).
5.3. A general role for IFN-inducible GTPases in the antiviral innate
immune response?
Interestingly, current knowledge of IFN-inducible GTPases
suggests that membrane disruption of ROs by IFN-g inducible
GTPases might be part of a common antiviral mechanism that
utilizes IFN-inducible GTPases to combat viral infection. Aside
from IRGs and GBPs, other families of dynamin-like IFN-inducible
GTPases exist, such as myxovirus resistance proteins (Mx) and the
very large IFN-inducible GTPases (VLIGs) [116]. These enzymes are
also known to have antiviral properties against a variety of viruses
(reviewed in [116]). For example, the protective role of Mx proteins
has been demonstrated for orthomyxoviruses such as influenza,
lentiviruses such as human immunodeficiency virus (HIV) 1, and,
interestingly, several +RNA viruses belonging to the picornaviridae
and togaviridae [116]. Moreover, based on evolutionary studies, it
was recently suggested that Mx proteins mediate protection
against even a wider variety of viruses [142]. In contrast to IFN-g
inducible IRGs and GBPs, expression of Mx proteins is induced by
IFNs type I and III, implying that all IFN types are capable of
inducing IFN-inducible GTPases [116]. Therefore, all cell types
known to respond to IFNs could theoretically induce a variety of
IFN-inducible GTPases in response to viral infection. In the case of
+RNA viruses, it is intriguing that multiple studies demonstrated
how MxB suppresses replication of HIV-1 by targeting the viral
capsid protein [143–145], given the parallels between retroviral
capsids and +RNA virus ROs [146]. In conclusion, these findings
again suggest a general function for IFN-inducible GTPase effectors
in the targeting of viral intracellular membrane structures that
function to shield away viral components away from the cytosol.
6. Concluding remarks
Rearrangement of host membranes into ROs is considered a
hallmark of +RNA virus infection. ROs are believed to have at least a
dual role in +RNA virus infection and innate immune evasion, as
they facilitate efficient RNA replication while shielding viral RNA
from the host antiviral response machinery. As viral RNA is a very
potent inducer of antiviral signaling, we focused on how both the
biochemical and spatial organization allows the innate immune
system to convert detection of viral RNA to an antiviral state. In
addition, we described part of the divergent methods by which
+RNA viruses impair antiviral signaling surrounding their RNA
replication, transcription, and translation in order to establish
infection. At last, based on recent studies that demonstrated how
IFN-g inducible GTPases are capable of disrupting PVs, we
discussed the possibility of a general function of IFN-inducible
GTPases in the targeting of viral ROs. In summary, upon infection,
+RNA viruses hamper IFN and ISG induction at multiple levels to
decelerate antiviral innate immune signaling. In this process, the
formation of ROs enables rapid viral RNA replication while masking
it from the host. However, in case of sufficient activation ofIFN-inducible GTPases by IFN-I and –III originating from various
cell types, or IFN-II produced by specialized immune cells,
disruption of ROs by IFN-inducible GTPases may result in enhanced
exposure of viral RNA, thereby amplifying the innate immune
response and ensuring efficient clearance of the virus. However,
considering the differences in morphology and origin of ROs, the
variety of infection dynamics within the category of +RNA viruses,
and a lack of knowledge regarding the exact mechanism(s) of
disruption of non/aberrant-self membrane structures by IFN-
inducible GTPases and possibly other factors, extensive further
research is required to elucidate whether this process plays a
general role in +RNA virus infection, and might open possibilities
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